KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Asset Writedowns and Impairment (2016 - 2022)

Travere Therapeutics' Asset Writedowns and Impairment history spans 7 years, with the latest figure at -$1.0 million for Q4 2022.

  • For Q4 2022, Asset Writedowns and Impairment fell 17.96% year-over-year to -$1.0 million; the TTM value through Dec 2022 reached $1.0 million, up 108.63%, while the annual FY2025 figure was $684000.0, 75.74% down from the prior year.
  • Asset Writedowns and Impairment reached -$1.0 million in Q4 2022 per TVTX's latest filing, down from $329000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $25.5 million in Q1 2019 to a low of -$1.0 million in Q4 2022.
  • Average Asset Writedowns and Impairment over 4 years is $2.9 million, with a median of $481000.0 recorded in 2021.
  • Peak YoY movement for Asset Writedowns and Impairment: tumbled 139.28% in 2021, then surged 94.87% in 2022.
  • A 4-year view of Asset Writedowns and Impairment shows it stood at $25.5 million in 2019, then plummeted by 91.27% to $2.2 million in 2020, then crashed by 139.28% to -$874000.0 in 2021, then decreased by 17.96% to -$1.0 million in 2022.
  • Per Business Quant, the three most recent readings for TVTX's Asset Writedowns and Impairment are -$1.0 million (Q4 2022), $329000.0 (Q3 2022), and $792000.0 (Q2 2022).